Ubiquitin-specific peptidase 22 functions and its involvement in disease

Johanna Melo-Cardenas; Yusi Zhang; Donna D. Zhang; Deyu Fang

doi:10.18632/oncotarget.8602

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Ubiquitin-specific peptidase 22 functions and its involvement in disease

Johanna Melo-Cardenas, Yusi Zhang, Donna D. Zhang and Deyu Fang _

PDF | HTML | How to cite

Oncotarget. 2016; 7:44848-44856. https://doi.org/10.18632/oncotarget.8602

Metrics: PDF 2201 views | HTML 4274 views | ?

Abstract

Johanna Melo-Cardenas1, Yusi Zhang1, Donna D. Zhang2 and Deyu Fang1,2

1 Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

2 Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, USA

Correspondence to:

Deyu Fang, email:

Keywords: USP22, deubiquitylation, cancer, oncogene, ataxia

Received: October 15, 2015 Accepted: March 10, 2016 Published: April 05, 2016

Abstract

Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8602

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Ubiquitin-specific peptidase 22 functions and its involvement in disease

Abstract